ArticleOncology letters2017

Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.

Yasuhiro Arakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.